These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 14979058)

  • 41. JNK1 is not essential for TNF-mediated joint disease.
    Köller M; Hayer S; Redlich K; Ricci R; David JP; Steiner G; Smolen JS; Wagner EF; Schett G
    Arthritis Res Ther; 2005; 7(1):R166-73. PubMed ID: 15642137
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Inflammatory cytokine mediated anti-anabolic effects: a potential mechanism in rheumatoid cartilage degeneration].
    Aigner T; Vornehm SI; Belke J; von der Mark K; Kirchner T
    Verh Dtsch Ges Pathol; 1996; 80():282-7. PubMed ID: 9065028
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thrombogenicity of TNF alpha in rheumatoid arthritis defined through biological probes: TNF alpha blockers.
    Ferraccioli G; Gremese E
    Autoimmun Rev; 2004 Jun; 3(4):261-6. PubMed ID: 15246021
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytokinin panel in rheumatoid arthritis and correlation with histological patterns of synovitis -- active type of disease.
    Avrămescu C; Vere CC; Mărgăritescu C; Turculeanu A; Bălăşoiu M; Rogoz S
    Rom J Morphol Embryol; 2005; 46(2):87-92. PubMed ID: 16286991
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inflammatory cytokine levels in paw tissues during development of rat collagen-induced arthritis: effect of FK506, an inhibitor of T cell activation.
    Magari K; Miyata S; Ohkubo Y; Mutoh S
    Inflamm Res; 2004 Sep; 53(9):469-74. PubMed ID: 15551000
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Myelodysplasia and anemia of chronic disease in human tumor necrosis factor-alpha transgenic mice.
    Capocasale RJ; Makropoulos DA; Achuthanandam R; Stowell N; Quinn J; Rafferty PA; O'Brien J; Emmell E; Bugelski PJ
    Cytometry A; 2008 Feb; 73(2):148-59. PubMed ID: 18205195
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Rheumatoid arthritis, inflammation, and atherosclerosis].
    Hürlimann D; Enseleit F; Ruschitzka F
    Herz; 2004 Dec; 29(8):760-8. PubMed ID: 15599672
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of tumour necrosis factor receptor-expressing macrophages by interleukin-10 and macrophage colony-stimulating factor in rheumatoid arthritis.
    Takasugi K; Yamamura M; Iwahashi M; Otsuka F; Yamana J; Sunahori K; Kawashima M; Yamada M; Makino H
    Arthritis Res Ther; 2006; 8(4):R126. PubMed ID: 16859503
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intervention of an inflammation amplifier, triggering receptor expressed on myeloid cells 1, for treatment of autoimmune arthritis.
    Murakami Y; Akahoshi T; Aoki N; Toyomoto M; Miyasaka N; Kohsaka H
    Arthritis Rheum; 2009 Jun; 60(6):1615-23. PubMed ID: 19479878
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Recent topics in histopathology associated with joint destruction in rheumatoid arthritis].
    Sawai T; Uzuki M
    Clin Calcium; 2009 Mar; 19(3):325-38. PubMed ID: 19252242
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A tumor necrosis factor receptor loop peptide mimic inhibits bone destruction to the same extent as anti-tumor necrosis factor monoclonal antibody in murine collagen-induced arthritis.
    Saito H; Kojima T; Takahashi M; Horne WC; Baron R; Amagasa T; Ohya K; Aoki K
    Arthritis Rheum; 2007 Apr; 56(4):1164-74. PubMed ID: 17393436
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pathogenesis of bone and cartilage destruction in rheumatoid arthritis.
    Goldring SR
    Rheumatology (Oxford); 2003 May; 42 Suppl 2():ii11-6. PubMed ID: 12817090
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Involvement of the kinin-forming system in the physiopathology of rheumatoid inflammation.
    Sharma JN
    Agents Actions Suppl; 1992; 38 ( Pt 3)():343-61. PubMed ID: 1334358
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute stress suppresses pro-inflammatory cytokines TNF-alpha and IL-1 beta independent of a catecholamine-driven increase in IL-10 production.
    Connor TJ; Brewer C; Kelly JP; Harkin A
    J Neuroimmunol; 2005 Feb; 159(1-2):119-28. PubMed ID: 15652410
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytokine expression and networks in rheumatoid arthritis: rationale for anti-TNF alpha antibody therapy and its mechanism of action.
    Feldmann M; Brennan FM; Williams RO; Elliott MJ; Maini RN
    J Inflamm; 1995-1996; 47(1-2):90-6. PubMed ID: 8913935
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer.
    Wang HJ; Yu CL; Kishi H; Motoki K; Mao ZB; Muraguchi A
    Chin Med J (Engl); 2006 Aug; 119(16):1365-73. PubMed ID: 16934183
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanisms for modulating TNF alpha in immune and inflammatory disease.
    Baugh JA; Bucala R
    Curr Opin Drug Discov Devel; 2001 Sep; 4(5):635-50. PubMed ID: 12825458
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Destruction of articular cartilage].
    Koike T
    Clin Calcium; 2006 Sep; 16(9):1543-47. PubMed ID: 16951481
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interleukin-18: a therapeutic target in rheumatoid arthritis?
    McInnes IB; Liew FY; Gracie JA
    Arthritis Res Ther; 2005; 7(1):38-41. PubMed ID: 15642152
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of TNF alpha during maturation of dendritic cells results in the development of semi-mature cells: a potential mechanism for the beneficial effects of TNF alpha blockade in rheumatoid arthritis.
    van Lieshout AW; Barrera P; Smeets RL; Pesman GJ; van Riel PL; van den Berg WB; Radstake TR
    Ann Rheum Dis; 2005 Mar; 64(3):408-14. PubMed ID: 15256380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.